Le Lézard
Classified in: Health
Subject: SCZ

Boomers Forever Young's Clarity Factor Wins Best All-Natural Nootropic for Senior Brain Health


Boomers Forever Young, a Florida-based supplier of nutritional supplements for older adults, has won the award for "Best All-Natural Nootropic for Senior Brain Health" from Better Nutrition News, a digital publication. This entrepreneurial enterprise is notable among its peers for its comprehensive focus on addressing the special nutritional and supplement needs of Baby Boomers?seniors who are living longer, more active, and involved lives.

NEW YORK

,

Sept. 25, 2023

/PRNewswire/ --  Boomers Forever Young, a provider of unique nutritional supplements for the Baby Boom generation, has been honored by Better Nutrition News for offering the Best All-Natural Nootropic for Senior Brain Health. Tailored to the particular needs of older consumers, Boomers Forever Young's Clarity Factor offers a unique nootropic supplement for those over 40, combining key herbs and vitamins to support overall health and optimal mental wellness. Formulated for peak brain function, Clarity Factor promotes increased blood flow to the brain, optimizing oxygen and nutrient delivery to enhance focus and concentration. [See full press release.]

The global nootropics market was valued at USD $10.9 billion in 2021 and is expected to reach USD $30.75 billion by 2029, increasing at a compound annual growth rate (CAGR) of 13.85%. Increasing awareness of nootropics' effectiveness in addressing age-related cognitive decline is driving the growth of the nootropics market. As the global population ages, cognitive decline is becoming a major concern for a growing number of consumers. Nootropics have shown promise in preventing or delaying cognitive decline, making them an appealing option for seniors.

Nootropics are also expected to be used as supplements for managing age-related diseases such as dementia, Alzheimer's disease, and Parkinson's disease; this usage is leading to an increase in nootropic market demand, generating further opportunities for Boomers Forever Young's Clarity Factor.

The company's flagship product, Boomer Boost, is a comprehensive, all-in-one nutritional supplement. Comprising 70 carefully selected ingredients, including amino acids, fatty acids, and specialty nutrients, it provides a foundation for complete nutrition far beyond a regular multivitamin.

Boomers Forever Young was co-founded by Larry Daudelin and President Bob Gilpatrick. Its products are distributed directly to consumers online and on a wholesale basis. [See full press release.]

About

Better Nutrition News is a digital publication providing continuously updated high-quality content about diet, nutrition, and supplementation to ensure the best health, wellness, and longevity for its readers.

Contact:
Carol Roundtree
718-965-1216
365804@email4pr.com

SOURCE Better Nutrition News; Boomers Forever Young


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: